Learning | Cancer

Research

The role of circulating tumour DNA in guiding cancer treatment and future applications

An overview of current and future applications of circulating tumour DNA in common solid tumours and the implications on treatment.…

Published: 23 September 2022

Learning

Medication restrictions for patients receiving CAR-T therapy

To assure the quality of CAR-T therapy and optimise the chances of successful treatment, pharmacists caring for CAR-T patients must be aware of the medication restrictions — prior to and following treatment — and their rationale.…

Published: 5 July 2022

Learning

Renal cancer: management

An overview of the most common forms of renal cancer, treatment options and the role of pharmacists in its management.…

Published: 28 June 2022

Supported content

Learning

Bladder cancer: management

An overview of the different types of bladder cancer, treatment options and the role of pharmacists in its management.…

Published: 10 May 2022

Supported content

Learning

Prostate cancer: recognition and diagnosis

An overview of prostate cancer for pharmacists, including early detection and prevention, testing and diagnosis.…

Published: 17 August 2021

Learning

Cervical cancer prevention: advice and services

With the uptake of cervical screening at 70–73% in the UK, it is important for pharmacy teams to recognise the symptoms of cervical cancer, as well as provide advice on prevention strategies.…

Published: 29 September 2020

Learning

Cancer-associated thrombosis

Venous thromboembolism is a complication of cancer that pharmacists should understand to ensure that their patients have the best possible outcomes. …

Published: 8 September 2020

Learning

Implementing chimeric antigen receptor T-cell therapy in practice

How pharmacists can ensure the safe delivery of chimeric antigen receptor T-cell therapy by ensuring governance, operational and clinical requirements are met.…

Published: 22 May 2020

Learning